Pharmaceutical News

RSS

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria.

25 Aug 2011

Webinar on Prescription Drug Abuse in Workers' Comp

Joseph Paduda, principal of Health Strategy Associates, will present "Prescription Drug Abuse in Workers' Comp," an hour-long webinar on Thursday, Sept. 1, starting 1 p.m. (PDT)/ 4 p.m. EDT.

25 Aug 2011

Foreign drug manufacturing, testing raise regulatory and ethical concerns

JAMA discusses "a recent report from the Pew Health Group about the growing risks of substandard and counterfeit medications resulting from the increasing overseas production of pharmaceuticals and their ingredients."

25 Aug 2011

Researchers discover how antipsychotic drugs manage symptoms of schizophrenia

The classic symptoms of schizophrenia - paranoia, hallucinations, the inability to function socially-can be managed with antipsychotic drugs. But exactly how these drugs work has long been a mystery.

25 Aug 2011

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

The U.S. Food and Drug Administration today approved Botox injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.

25 Aug 2011

NMS Labs develops substance identification tests for nine 'bath salts' compounds

In keeping up with drug abuse trends, NMS Labs has developed substance identification tests for the nine "bath salts" compounds listed in the recently approved PA Senate Bill 1006.

25 Aug 2011

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

Cortex Pharmaceuticals, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent that protects the use of AMPAKINE molecules for the treatment or prevention of respiratory depression.

25 Aug 2011

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

25 Aug 2011

Mylan subsidiary to exclusively offer EpiPen 2-Pak and EpiPen Jr 2-Pak Auto-Injector

Dey Pharma, L.P., a subsidiary of Mylan Inc., today announced that Dey will exclusively offer the EpiPen 2-Pak and EpiPen Jr 2-Pak (epinephrine) Auto-Injector 0.3/0.15 mg, to encourage physicians and patients to follow recommendations by the National Institute of Allergy and Infectious Diseases (NIAID).

24 Aug 2011

A pain-free way of tackling dental decay

Researchers at the University of Leeds have discovered a pain-free way of tackling dental decay that reverses the damage of acid attack and re-builds teeth as new.

24 Aug 2011

Call for open challenges in nanomedicine

"Nanomedicine is certainly the most promising enabling technology to achieve breakthroughs in medical technologies. It will strongly contribute to driving the future of medicine. A first step to initiate the necessary actions will be done in October in Barcelona." says Bertrand Loubaton, Director at GE Healthcare and chairman of the European Technology Platform ETPN.

24 Aug 2011

FDA grants fast track designation for Pharmasset's PSI-938 to treat chronic HCV infection

Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration (FDA) for PSI-938 for the treatment of chronic hepatitis C virus (HCV) infection.

24 Aug 2011

$New invasive procedures may help patients with chronic refractory headache$

New invasive procedures may help patients with chronic refractory headache

Cluster headache has a substantial detrimental effect on quality of life. New invasive procedures, such as hypothalamic deep brain stimulation and bilateral occipital nerve stimulation, may help patients with chronic refractory headache.

24 Aug 2011

New Pressurized Olfactory Device shows direct CNS effect of morphine

A simple new approach to nasal drug administration may allow morphine and other strong pain medications to be targeted directly to the central nervous system (CNS), reports an experimental study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Aug 2011

First international conference on developmental, translational and clinical pharmacogenomics

The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.

24 Aug 2011

Health Canada accepts Sunovion Pharmaceuticals Canada's lurasidone NDS for review

Sunovion Pharmaceuticals Canada Inc., formerly Sepracor Pharmaceuticals, Inc., today announced that the New Drug Submission (NDS) for Lurasidone HCl, for the treatment of adult patients with schizophrenia has been accepted for review by Health Canada. The NDS was submitted to Health Canada in June 2011 and will receive a standard review.

24 Aug 2011

Research may help explain why live attenuated influenza vaccine elicits protection

New research from the Trudeau Institute may help to explain why live attenuated influenza vaccine (LAIV), commonly known as FluMist, elicits protection.

24 Aug 2011

Daily exercise can work as well as second antidepressant drug

Exercise can be as effective as a second medication for as many as half of depressed patients whose condition have not been cured by a single antidepressant medication.

24 Aug 2011

Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury

The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

24 Aug 2011

Only 20.6% of Medicaid-covered Ohio youths complete full six month antidepressant treatment

About half of Medicaid-covered children and adolescents in Ohio who are in treatment for depression complete their first three months of prescribed antidepressants, and only one-fifth complete the recommended minimum six-month course of drugs to treat depression, new research suggests.

24 Aug 2011

Pharmaceutical News

Redesigned vancomycin can kill deadliest antibiotic-resistant bacteria

Webinar on Prescription Drug Abuse in Workers' Comp

Foreign drug manufacturing, testing raise regulatory and ethical concerns

Researchers discover how antipsychotic drugs manage symptoms of schizophrenia

Allergan receives FDA approval for Botox to treat specific form of urinary incontinence

NMS Labs develops substance identification tests for nine 'bath salts' compounds

USPTO issues Notice of Allowance for Cortex AMPAKINE molecules to treat respiratory depression

FDA approves Allergan's BOTOX to treat specific form of urinary incontinence

Mylan subsidiary to exclusively offer EpiPen 2-Pak and EpiPen Jr 2-Pak Auto-Injector

A pain-free way of tackling dental decay

Call for open challenges in nanomedicine

FDA grants fast track designation for Pharmasset's PSI-938 to treat chronic HCV infection

New invasive procedures may help patients with chronic refractory headache

New Pressurized Olfactory Device shows direct CNS effect of morphine

First international conference on developmental, translational and clinical pharmacogenomics

Health Canada accepts Sunovion Pharmaceuticals Canada's lurasidone NDS for review

Research may help explain why live attenuated influenza vaccine elicits protection

Daily exercise can work as well as second antidepressant drug

Simvastatin may reduce spinal cord damage from ischemia/reperfusion injury

Only 20.6% of Medicaid-covered Ohio youths complete full six month antidepressant treatment

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News